StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.89−0.05 (-2.58%)

Close on Nov 16, 2026Market cap $18.22MP/E –Yield –

Edesa Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Edesa Biotech's enterprise value was $11.09M on Nov 11, 2026, against $1.71M a year earlier. Over the last 5 years it ranged from -$2.44M to $516.12M, with a median of $14.46M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.09M–
2025Dec 31, 2025-$650.84K-114.7%
2024Dec 31, 2024$4.42M-49.2%
2023Dec 29, 2023$8.69M-69.9%
2022Dec 30, 2022$28.90M-94.4%
2021Dec 31, 2021$516.12M+85.1%
2020Dec 31, 2020$278.83M+32.6%
2019Dec 31, 2019$210.34M+8.5%
2018Dec 31, 2018$193.92M-44.8%
2017Dec 29, 2017$351.35M-58.8%
2016Dec 30, 2016$852.76M-59.8%
2015Dec 31, 2015$2.12B-44.2%
2014Dec 31, 2014$3.80B-11.1%
2013Dec 31, 2013$4.28B+703.4%
2012Dec 31, 2012$532.19M–

More Edesa Biotech figures

See a number that looks wrong?